Pharmacology Considerations of Future ART/PrEP Regimens - Marta Boffito, MD, PhD, FRCP

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Session 2: Discussion with the Audience | International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

CON Healthcare Provider: Oral Daily and/or On Demand PrEP - Laura Waters, MD, FRCP

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

PRO Healthcare Provider: Long-Acting Injectables for PrEP - Steve Taylor, MBChB, FRCP, PhD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

#2: Pharmacokinetics of sotrovimab, a monoclonal antibody for early treatment of mild-to-moderate COVID-19 - Asma El-Zailik

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Managing HIV Patients with Limited Treatment Options - 2nd EU Series, Spanish Edition

Managing HIV Patients with Limited Treatment Options - EU Series 2022 Second Edition

Managing HIV Patients with Limited Treatment Options - 2nd EU Series, Italian Edition

Managing HIV Patients with Limited Treatment Options - EU Series 2022 Second Edition

Managing HIV Patients with Limited Treatment Options - 2nd EU Series, German Edition

Managing HIV Patients with Limited Treatment Options - EU Series 2022 Second Edition

European Stigma & Discrimination Forum 2023

International Viral Hepatitis Elimination Meeting (IVHEM) 2023

HIV Cascade of Care: Closing the Gap

CON Standpoint - Laura Waters, MD, FRCP

2DR Debate: Should the Majority of People Living with HIV Be on a 2DR Regimen?

PRO Standpoint - Jürgen Rockstroh, MD

2DR Debate: Should the Majority of People Living with HIV Be on a 2DR Regimen?

CON Standpoint - Laura Waters, MD, FRCP

2DR Debate: Should the Majority of People Living with HIV Be on a 2DR Regimen?

PRO Standpoint - Jürgen Rockstroh, MD

2DR Debate: Should the Majority of People Living with HIV Be on a 2DR Regimen?

Diagnostic Innovations for COVID-19 Response - Elena Ivanova Reipold, MD, PhD

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

Impact of COVID-19 Pandemic on the Physical Health of School of Healthcare Science Students at a Selected Tertiary Institution in Gauteng (P#7) - Nontembiso Magida

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

Exploring the Effectiveness of Ghana’s COVID-19 Policy Responses (P#6) - Shirley Crankson

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

High seroprevalence of anti-SARS-CoV-2 antibodies in the capital city of Chad - Deutou Wondeu Andrillene Laure

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

High seroprevalence of anti-SARS-CoV-2 antibodies in the capital city of Chad | Deutou Wondeu Andrillene Laure

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

SARS-CoV-2 Genomic Surveillance and Reliability of PCR Point Mutation Assay (EscapePLEX kit) for the Rapid Detection of Variants of Concern in Cameroon - Davy Hyacinthe Gouissi Anguechia

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

SARS-CoV-2 Genomic Surveillance and Reliability of PCR Point Mutation Assay (EscapePLEX kit) for the Rapid Detection of Variants of Concern in Cameroon | Davy Hyacinthe Gouissi Anguechia

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

Viral dynamics and factors favouring the duration of covid-19 positivity: Evidence from the first-three epidemiological waves in Cameroon - Aurelie Minelle Kengni Ngueko

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

Viral dynamics and factors favouring the duration of covid-19 positivity: Evidence from the first-three epidemiological waves in Cameroon | Aurelie Minelle Kengni Ngueko

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022